Aarti Drugs Limited (AARTIDRUGS:NSE) Annual Income Statement ()
AARTIDRUGS:NSE Quarterly Financials ()
Frequently Asked Questions About Aarti Drugs Limited (AARTIDRUGS:NSE) Stock
Aarti Drugs Limited's (AARTIDRUGS:NSE) last reported annual revenue was INR 25.29 Billion.
Aarti Drugs Limited's (AARTIDRUGS:NSE) annual revenue growth rate based on the revenue reported in the past 5 years is : 10.13%
Aarti Drugs Limited's(AARTIDRUGS:NSE) is profitable as of its last reported annual financials.
The net profit margin for Aarti Drugs Limited's(AARTIDRUGS:NSE) from its laster reported year is 6.78%
The return on equity (ROE) for Aarti Drugs Limited's(AARTIDRUGS:NSE) from its last reported annual financials is : 13.87%
The return on assets (ROA) for Aarti Drugs Limited's(AARTIDRUGS:NSE) from its last reported annual financials is : 6.93%
The return on invested capital (ROIC) for Aarti Drugs Limited's(AARTIDRUGS:NSE) from its last reported annual financials is : 11.04%
The Debt to Equity ratio for Aarti Drugs Limited's(AARTIDRUGS:NSE) from its last reported annual financials is : 21.48%
The dividend yield for Aarti Drugs Limited's(AARTIDRUGS:NSE) from its laster reported year is 0.20%
Aarti Drugs Limited's(AARTIDRUGS:NSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AARTIDRUGS:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
